Belgium· BE-AMP-SAM580106-00
Tukysa 150 mg
A tucatinib product containing tucatinib, registered in Belgium by Pfizer Europe MA. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Tucatinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EH03 (tucatinib), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Tucatinib · ATC L01EH03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tucatinib costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tucatinib · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- FR France$3.96
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Tucatinib
- Manufacturer
- Pfizer Europe MA
- Country
- Belgium (BE)
- ATC code
- L01EH03
- ATC class
- Tucatinib
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7738560
- be_apb4420584
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
309 interactions on record for tucatinib.
Graded by severity as the source publishes them — 126 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tucatinib · interactions on record
309 records
- 126 severe
- 173 moderate
- 10 minor
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- BudesonideA07EA06severe
- EliglustatA16AX10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tucatinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandTukysa 150 mg, FilmtablettenPfizer AG
- CzechiaTUKYSAPfizer Europe MA EEIG, Bruxelles
- SpainTUKYSA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULAPfizer Europe Ma Eeig
- FinlandTUKYSAPfizer Europe MA EEIG
- FranceTUKYSA 150 mg, comprimé pelliculéPFIZER EUROPE MA EEIG (BELGIQUE)
- IrelandTUKYSA 150 mg film-coated tabletsPfizer Europe MA EEIG
- IcelandTukysaPfizer Europe MA EEIG*
- NetherlandsTukysa 150 mg, filmomhulde tabletPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tukysa
- Liechtenstein · Tukysa
- Norway · Tukysa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f87d8413-7ab3-4bf8-8f2e-8ea59094ddb1 GET /v1/drugs/f87d8413-7ab3-4bf8-8f2e-8ea59094ddb1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Tukysa 150 mg",
"name_fr": "Tukysa 150 mg",
"name_nl": "Tukysa 150 mg",
"amp_code": "SAM580106-00",
"strengths": [
"150.0000",
"150.0000",
"150.0000",
"27.6400"
],
"pack_count": 1,
"substances": [
"Tucatinib",
"Sodium"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Tucatinib",
"authorisation_numbers": [
"EU/1/20/1526/002"
]
}See everything about tucatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.